The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(4-(3-aminopyrrolidine-1-carbonyl)phenethylamino)quinazoline-6-carbonitrile ID: ALA4858679
PubChem CID: 71679495
Max Phase: Preclinical
Molecular Formula: C22H22N6O
Molecular Weight: 386.46
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1ccc2ncnc(NCCc3ccc(C(=O)N4CCC(N)C4)cc3)c2c1
Standard InChI: InChI=1S/C22H22N6O/c23-12-16-3-6-20-19(11-16)21(27-14-26-20)25-9-7-15-1-4-17(5-2-15)22(29)28-10-8-18(24)13-28/h1-6,11,14,18H,7-10,13,24H2,(H,25,26,27)
Standard InChI Key: AACMTGFJUPSOMN-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
31.0725 -6.9378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0713 -7.7574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7794 -8.1663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7776 -6.5290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4862 -6.9342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4851 -7.7549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1913 -8.1639 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.9031 -7.7569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9043 -6.9362 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.1936 -6.5226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3652 -6.5299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6574 -6.1215 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.1936 -5.7055 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.9013 -5.2969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9013 -4.4797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6090 -4.0711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3137 -4.4837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0210 -4.0758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0214 -3.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3088 -2.8493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6044 -3.2596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7286 -2.8482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4369 -3.2559 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.7275 -2.0311 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.5225 -4.0654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3220 -4.2342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7297 -3.5259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1821 -2.9195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6554 -4.9803 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
11 12 3 0
1 11 1 0
10 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
22 23 1 0
22 24 2 0
23 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 23 1 0
26 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 386.46Molecular Weight (Monoisotopic): 386.1855AlogP: 2.33#Rotatable Bonds: 5Polar Surface Area: 107.93Molecular Species: BASEHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.38CX LogP: 1.81CX LogD: -0.13Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.70Np Likeness Score: -1.52
References 1. (2019) Cdk8/cdk19 selective inhibitors and their use in anti-metastatic and chemopreventive methods for cancer,